Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2691]

New cancer drug shows promise in mesothelioma trial

New cancer drug shows promise in mesothelioma trial

KRAS-targeting drugs show promise for rare appendix cancer

KRAS-targeting drugs show promise for rare appendix cancer

Fasting primes gut microbiome to improve intestinal recovery after radiation treatment

Fasting primes gut microbiome to improve intestinal recovery after radiation treatment

Genome editing in rats enables more accurate ER+ breast cancer models

Genome editing in rats enables more accurate ER+ breast cancer models

Hidden metastases reveal clues to colorectal cancer recurrence

Hidden metastases reveal clues to colorectal cancer recurrence

American Cancer Society reports latest global cancer statistics; Cancer cases approach 21 million worldwide, with burden projected to surge 67% by 2050

American Cancer Society reports latest global cancer statistics; Cancer cases approach 21 million worldwide, with...

ESMO GI 2026: Blood test may help identify which colorectal cancer patients with liver metastases are most likely to benefit from chemotherapy after surgery

ESMO GI 2026: Blood test may help identify which colorectal cancer patients with liver metastases are most likely...

Novel biomarker research offers new hope in the fight against colorectal cancer

Novel biomarker research offers new hope in the fight against colorectal cancer

Radioligand therapy significantly prolongs progression-free survival in patients with the most common type of neuroendocrine tumours compared to standard of care

Radioligand therapy significantly prolongs progression-free survival in patients with the most common type of...

Do cancer screening rates differ across sexual orientation and gender identity?

Do cancer screening rates differ across sexual orientation and gender identity?

More from ecancer